PL387516A1 - Kompozycja farmaceutyczna zawierająca 4-[(4-metylopiperazyn-1-ylo)metylo]-N-[4-metylo-3-[(4-pirydyn-3-ylopirymidyn-2-ylo)amino]fenylo]benzamid, sposób jej wytwarzania oraz postacie leku zawierające tę kompozycję - Google Patents

Kompozycja farmaceutyczna zawierająca 4-[(4-metylopiperazyn-1-ylo)metylo]-N-[4-metylo-3-[(4-pirydyn-3-ylopirymidyn-2-ylo)amino]fenylo]benzamid, sposób jej wytwarzania oraz postacie leku zawierające tę kompozycję

Info

Publication number
PL387516A1
PL387516A1 PL387516A PL38751609A PL387516A1 PL 387516 A1 PL387516 A1 PL 387516A1 PL 387516 A PL387516 A PL 387516A PL 38751609 A PL38751609 A PL 38751609A PL 387516 A1 PL387516 A1 PL 387516A1
Authority
PL
Poland
Prior art keywords
methyl
metyl
benzamide
pyrimidin
piperazine
Prior art date
Application number
PL387516A
Other languages
English (en)
Inventor
Andrzej Ostrowicz
Original Assignee
Biofarm Spółka Z Ograniczoną Odpowiedzialnością
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Biofarm Spółka Z Ograniczoną Odpowiedzialnością filed Critical Biofarm Spółka Z Ograniczoną Odpowiedzialnością
Priority to PL387516A priority Critical patent/PL387516A1/pl
Publication of PL387516A1 publication Critical patent/PL387516A1/pl

Links

PL387516A 2009-03-16 2009-03-16 Kompozycja farmaceutyczna zawierająca 4-[(4-metylopiperazyn-1-ylo)metylo]-N-[4-metylo-3-[(4-pirydyn-3-ylopirymidyn-2-ylo)amino]fenylo]benzamid, sposób jej wytwarzania oraz postacie leku zawierające tę kompozycję PL387516A1 (pl)

Priority Applications (1)

Application Number Priority Date Filing Date Title
PL387516A PL387516A1 (pl) 2009-03-16 2009-03-16 Kompozycja farmaceutyczna zawierająca 4-[(4-metylopiperazyn-1-ylo)metylo]-N-[4-metylo-3-[(4-pirydyn-3-ylopirymidyn-2-ylo)amino]fenylo]benzamid, sposób jej wytwarzania oraz postacie leku zawierające tę kompozycję

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
PL387516A PL387516A1 (pl) 2009-03-16 2009-03-16 Kompozycja farmaceutyczna zawierająca 4-[(4-metylopiperazyn-1-ylo)metylo]-N-[4-metylo-3-[(4-pirydyn-3-ylopirymidyn-2-ylo)amino]fenylo]benzamid, sposób jej wytwarzania oraz postacie leku zawierające tę kompozycję

Publications (1)

Publication Number Publication Date
PL387516A1 true PL387516A1 (pl) 2010-09-27

Family

ID=42940972

Family Applications (1)

Application Number Title Priority Date Filing Date
PL387516A PL387516A1 (pl) 2009-03-16 2009-03-16 Kompozycja farmaceutyczna zawierająca 4-[(4-metylopiperazyn-1-ylo)metylo]-N-[4-metylo-3-[(4-pirydyn-3-ylopirymidyn-2-ylo)amino]fenylo]benzamid, sposób jej wytwarzania oraz postacie leku zawierające tę kompozycję

Country Status (1)

Country Link
PL (1) PL387516A1 (pl)

Similar Documents

Publication Publication Date Title
HUS1900013I1 (hu) Vegyületek és készítmények mint protein kináz inhibitorok
IL229199A (en) N– (2– {2– dimethylaminoethyl-methylamino} –4 – methoxy-5 - {[4– (1-methylindol-3-yl) pyrimidine-2-yl] amino} phenyl) prop-2-anamide and salts acceptable in pharmacy Her, pharmaceuticals that include her and its use in the manufacture of cancer drugs
IL233677A (en) Benzysacazole Compounds Aminopyrazolo-Primidine Converted, Pharmaceuticals Containing Them, and Use of Drug Manufacturing Composition
IL232462A (en) Annals of 2- (1, 2, 3-triazole-2-ram) benzamide and 3- (3,2,1-triazole-2-ram) picolinamide, containing and using pharmaceutical preparations
IL214236A0 (en) Heterocyclic compounds, pharmaceutical compositions containing them, and their use as inhibitors of the glycine transporter 1
IL213141A0 (en) Preparation method of dihydroindene amide compounds, their pharmaceutical compositions containing compounds thereof and use as protein kinase inhibitor
ZA200804030B (en) Improved process for the preparation of 4-(benzimidazolylmethylamino)benzamides and the salts thereof
IL213623A (en) Compounds 4-piperazine-1-yl benzamide are produced and used in the preparation of a drug
IL225198A (en) Aminotetrahydropyrenic Compounds, Pharmaceutical Preparations Containing Them and Their Use in the Treatment of Diabetes
IL216132A (en) Heterocyclic carboxamide diamine compounds, their uses and their medicinal products and inhibitors
ZA201209381B (en) The use of inhibitors of bruton's tyrosine kinase (btk)
MX2011012344A (es) Sales de disacarina, acido difumarico, acido di-1-hidroxi-2-naftoi co y acido monobenzoico del 2-(4-((2-amino-4-metil-6-(pentilamino) pirimidin-5-il)metil)fenil)acetato de 4-(dimetilamino) butilo.
IL195947A (en) Manicured cyclic compounds and pharmaceutical preparations containing them for use @ for prevention @ and treatment @ for diabetes
AP2013007233A0 (en) l)-3-(trifluoromethyl phenylÜ benzamide solubilizeModified release of 4-methyl-3-[[4-(3-pyridinyl)-2- pyrimidinyl]amino]-N-5-(4-methyl-IH-imidazol-I-yd using organic acids
CL2007002930A1 (es) Un compuesto 4-[4-({[4-cloro-3-(trifluorometil)fenil]carbamoil}amino)-3-fluorofenoxi]-n-metilpiridin-2-carboxamida monohidratado; proceso de preparacion; composicion y combinacion farmaceutica; y uso para el tratamiento de trastornos hiperproliferati
IL189375A (en) Derivatives 1-Heterocyclicsulfonyl-3-Aminomethyl-5- (hetero-) aryl-1-h- Pyrol
IL206815A (en) Blockers of Triazo and Cyclo Diazu channels, pharmaceuticals including them and their use in the preparation of drugs for the treatment of diseases
IL209267A (en) Combinations containing methotrexate and dhodh inhibitors and their use in the preparation of the drug
IL226101A (en) Capsule Formulations of N- Tert-Butyl-3 - [(5-Methyl-2 - {[4- (2-Pyrrolidine-1-Illethoxy) Phenyl [Amino {Pyrimidine-4-Il) Amino] Benzinsulfonamide and Their Use in the Preparation of Drugs In myelofibrosis
IL206690A0 (en) Protein kinase inhibitors and their use in the preparation of medicaments
IL192442A0 (en) Novel cyclic urea derivatives, preparation thereof and pharmaceutical use thereof as kinase inhibitors
IL200947A (en) Desprithiocine polyether analogues and their use in the preparation of drugs for the treatment of diseases
IL223289A (en) The history of triazine and pharmaceutical preparations containing them for the treatment of type 2 diabetes
IL192415A0 (en) Pharmaceutical composition for the treatment of nail diseases
IL266097A (en) Citric acid acid salt of (R)-5-((E)-2-(pyrrolidine-3-yl)vinyl)pyrimidine, a pharmaceutical preparation containing the salt, use of the salt in the production of a medicine, salt for use, and method of production